Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness
- PMID: 19683746
- DOI: 10.1016/j.juro.2009.06.015
Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness
Abstract
Purpose: Adipose tissue has been suggested to contribute to the pathogenesis of various disease states, including prostate cancer. We investigated the association of cytokines and growth factors secreted by periprostatic adipose tissue with pathological features of aggressive prostate cancer.
Materials and methods: Periprostatic adipose tissue was harvested from patients undergoing radical prostatectomy and cultured for 24 hours to generate conditioned medium or snap frozen immediately for functional signaling profiling. Multiplex analysis of the periprostatic adipose tissue conditioned medium was used to detect cytokine levels and compared to patient matched serum from 7 patients. Interleukin-6 in serum and periprostatic adipose tissue conditioned medium was further analyzed by enzyme-linked immunosorbent assay and correlated with clinical variables, such as age, body mass index and Gleason score, in 45 patients. Interleukin-6 expression in periprostatic adipose tissue was determined by immunohistochemistry. Reverse phase protein microarray technology was used to analyze cell signaling networks in periprostatic adipose tissue.
Results: Interleukin-6 in periprostatic adipose tissue conditioned medium was approximately 375 times greater than that in patient matched serum and levels correlated with pathological grade. This finding was further extended by cell signaling analysis of periprostatic adipose tissue, which showed greater phosphorylation on Stat3 with high grade tumors (any component of Gleason score 4 or 5).
Conclusions: Higher Gleason score correlated with high levels of conditioned medium derived interleukin-6. Moreover, cell signaling analysis of periprostatic adipose tissue identified activated signaling molecules, including STAT3, that correlated with Gleason score. Since STAT3 is interleukin-6 regulated, these findings suggest that periprostatic adipose tissue may have a role in modulating prostate cancer aggressiveness by serving as a source of interleukin-6. Also, we found low numbers of inflammatory cells in the fat, suggesting that adipocytes are the major secretors of interleukin-6.
Comment in
-
New insights into the role of interleukin-6 in human prostate cancer.J Urol. 2009 Oct;182(4):1255-6. doi: 10.1016/j.juro.2009.07.073. Epub 2009 Aug 14. J Urol. 2009. PMID: 19683299 No abstract available.
-
Words of wisdom. Re: Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness.Eur Urol. 2010 Mar;57(3):541-2. doi: 10.1016/j.eururo.2009.12.016. Eur Urol. 2010. PMID: 20135758 No abstract available.
Similar articles
-
Periprostatic fat thickness on MRI: correlation with Gleason score in prostate cancer.AJR Am J Roentgenol. 2015 Jan;204(1):W43-7. doi: 10.2214/AJR.14.12689. AJR Am J Roentgenol. 2015. PMID: 25539273
-
Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.Cancer. 2002 Jun 15;94(12):3141-9. doi: 10.1002/cncr.10604. Cancer. 2002. PMID: 12115346
-
Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264
-
Obesity and prostate cancer: a role for adipokines.Eur Urol. 2007 Jul;52(1):46-53. doi: 10.1016/j.eururo.2007.03.054. Epub 2007 Mar 26. Eur Urol. 2007. PMID: 17399889 Review.
-
Obesity, adipokines, and prostate cancer (review).Int J Oncol. 2006 Mar;28(3):737-45. Int J Oncol. 2006. PMID: 16465380 Review.
Cited by
-
IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.World J Clin Oncol. 2011 Dec 10;2(12):384-96. doi: 10.5306/wjco.v2.i12.384. World J Clin Oncol. 2011. PMID: 22171281 Free PMC article.
-
Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.Mol Oncol. 2010 Dec;4(6):496-510. doi: 10.1016/j.molonc.2010.09.001. Epub 2010 Sep 16. Mol Oncol. 2010. PMID: 20934395 Free PMC article. Review.
-
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor.Biomedicines. 2021 Nov 15;9(11):1692. doi: 10.3390/biomedicines9111692. Biomedicines. 2021. PMID: 34829922 Free PMC article.
-
CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression.Plast Reconstr Surg. 2019 Mar;143(3):747-756. doi: 10.1097/PRS.0000000000005316. Plast Reconstr Surg. 2019. PMID: 30817646 Free PMC article.
-
Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine.Front Pharmacol. 2023 Jul 10;14:1145860. doi: 10.3389/fphar.2023.1145860. eCollection 2023. Front Pharmacol. 2023. PMID: 37492091 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous